EUVIMEDОткрийте EUVIMED
Open access · CC BY 4.0

Computational analyses of drug resistance mutations in katG and emb complexes in Mycobacterium tuberculosis

Aadam Basrai, Tom L Blundell, Arun Prasad Pandurangan iD

Proteins: Structure, Function, and Bioinformatics · 2025

DOI: 10.1002/prot.26684 ↗

At a glance

Journal article in Proteins: Structure, Function, and Bioinformatics, 2025. Written by Aadam Basrai and 2 co-authors. Institution: Victor Phillip Dahdaleh Heart and Lung Research Institute, Department of Medicine, University of Cambridge, Cambridge, UK. Major MEDLINE topics: Mycobacterium tuberculosis, Bacterial Proteins, Isoniazid, Antitubercular Agents. Cited 1 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust, Cystic Fibrosis Trust.

РезюмеSubjectsБиблиографски данниCiteRelated studies

Abstract (original language)

The number of antibiotic resistant pathogens is increasing rapidly, and with this comes a substantial socioeconomic cost that threatens much of the world. To alleviate this problem, we must use antibiotics in a more responsible and informed way, further our understanding of the molecular basis of drug resistance, and design new antibiotics. Here, we focus on a key drug‐resistant pathogen, Mycobacterium tuberculosis , and computationally analyze trends in drug‐resistant mutations in genes of the proteins embA , embB , embC , and katG , which play essential roles in the action of the first‐line drugs ethambutol and isoniazid. We use docking to predict binding modes of isoniazid to katG that agree with suggested binding sites found in our laboratory using cryo‐EM. Using mutant stability predictions, we recapitulate the idea that resistance occurs when katG's heme cofactor is destabilized rather than due to a decrease in affinity to isoniazid. Conversely, we have identified resistance mutations that affect the affinity of ethambutol more drastically than the affinity of the natural substrate of embB . With this, we illustrate that we can distinguish between the two types of drug resistance—cofactor destabilization and drug affinity reduction—suggesting potential uses in the prediction of novel drug‐resistant mutations.

Subjects

MeSH terms (MEDLINE)

Mycobacterium tuberculosisBacterial ProteinsIsoniazidAntitubercular AgentsMutationCatalaseMolecular Docking SimulationEthambutolDrug Resistance, BacterialBinding SitesProtein BindingComputational Biology

Author keywords

Mycobacterium tuberculosisantimicrobial drug resistanceethambutolinfectious diseasesisoniazidmachine learningmolecular dockingprotein stability prediction

Substances

katG protein, Mycobacterium tuberculosisBacterial ProteinsIsoniazidAntitubercular AgentsCatalaseEthambutol

Authors and institutions

  • Victor Phillip Dahdaleh Heart and Lung Research Institute, Department of Medicine, University of Cambridge, Cambridge, UK.

ORCID profiles: Arun Prasad Pandurangan

Funding

  • Wellcome Trust
  • Cystic Fibrosis Trust

Cite

APA

Basrai, A., Blundell, T. L., & Pandurangan, A. P. (2025). Computational analyses of drug resistance mutations in katG and emb complexes in Mycobacterium tuberculosis. Proteins: Structure, Function, and Bioinformatics. https://doi.org/10.1002/prot.26684

Vancouver

Basrai A, Blundell TL, Pandurangan AP. Computational analyses of drug resistance mutations in katG and emb complexes in Mycobacterium tuberculosis. Proteins: Structure, Function, and Bioinformatics. 2025. doi:10.1002/prot.26684

BibTeX
@article{Basrai2025,
  author = {Basrai, Aadam and Blundell, Tom L and Pandurangan, Arun Prasad},
  title = {Computational analyses of drug resistance mutations in katG and emb complexes in Mycobacterium tuberculosis},
  journal = {Proteins: Structure, Function, and Bioinformatics},
  year = {2025},
  doi = {10.1002/prot.26684}
}
Start for free →